Myungmoon Pharm. Co., Ltd.

1. Date of Establishment : Sep. 1st, 1983  
2. Date of Corporation founded : Jul. 8th, 1986 (a registration number-1151)  
3. Line of Business  
- Manufacture, wholesale, export and import of pharmaceuticals
- Selling of chemicals (with exception of a poison and chemical class)
- A wholesale business of non-pharmaceuticals
- The publication of a document definite promise about sale and delivery
- Division of labor of pharmaceuticals
- The business articles of food (health food)
- All the business attached to each an item
4. Products Composition
- Surgery : 17 Items incl. Atroda
- Gastro Intestinal : 9 Items incl. Recosta
- Cardio Vascular : 18 Items incl. Cartin Inj.
- Obstetrics and Gynecology : 7 Items incl. Libron
- Antibiotics : 9 Items incl. Cefaclor
- Anesthesiology : 15 Items incl. Provive
- Obesity : 14 Items incl. Topamin  
5. Net sales : 76.6Mil US$ (76.6 Bil Won) (The end of year 2007)
6. Patent  
- A process for solubilizing aceclofenac(Registration No. 10-069154, 2006.11.16)
- Novel Intermediate Compound for Valsartan and
Preparation Process of Valsartan Using thereof
(Open 10-2006-85073, 2006. 7. 26)
- Process for Manufacturing of Glimepiride (Open 10-2005-17776, 2005.2.23)
- Novel Intermediate Compound for Amlodipine Besylate and
Preparation Process of Amlodipine Besylate Using thereof
(Open 10-2005-122481, 2005. 12. 29)
- Preparation Process of Lacidipine (Application 10-2006-31654, 2006. 4. 6)
- Novel Intermediate Compound for Preparing Amlodipine, its Preparation
Process and Preparation Process of Amlodipine Using it
(Application 10-2006-103049, 2006. 10. 23)  
7. Expected sales for 2009 : 100.0Mil US$
8. Introduction.
We are one of the leading pharmaceutical manufacturers and named as Myung Moon Pharm. Co., Ltd. in Korea.
We are, not only, manufacturing, but also, distributing the finished drugs in Korea.